| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9646453 | Schizophrenia Research | 2005 | 9 Pages |
Abstract
The results suggest that fCBT is well tolerated and holds promise for reducing persistent positive symptoms.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Corinne Cather, David Penn, Michael W. Otto, Iftah Yovel, Kim T. Mueser, Donald C. Goff,